|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2000-1-4
|
|
pubmed:abstractText |
According to initial reports, stage 4 neuroblastoma patients with amplification of the MYCN proto-oncogene developed progressive disease within 8 months. The prognosis for such patients, however, should now be reevaluated in light of recent results achieved with up-to-date combination chemotherapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BesshoFF,
pubmed-author:EtohTT,
pubmed-author:HonnaTT,
pubmed-author:IwafuchiMM,
pubmed-author:KanekoMM,
pubmed-author:KawaKK,
pubmed-author:MimayaJJ,
pubmed-author:MiyataHH,
pubmed-author:MugishimaHH,
pubmed-author:NakadaKK,
pubmed-author:NakamuraTT,
pubmed-author:NozakiTT,
pubmed-author:OhhiraMM,
pubmed-author:OhnumaNN,
pubmed-author:SawadaTT,
pubmed-author:TsuchidaYY,
pubmed-author:YamamotoKK,
pubmed-author:YamatoKK,
pubmed-author:YokoyamaJJ,
pubmed-author:YoshizawaJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
17
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3216-20
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10506621-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10506621-Child, Preschool,
pubmed-meshheading:10506621-Cisplatin,
pubmed-meshheading:10506621-Cyclophosphamide,
pubmed-meshheading:10506621-DNA, Neoplasm,
pubmed-meshheading:10506621-Disease-Free Survival,
pubmed-meshheading:10506621-Doxorubicin,
pubmed-meshheading:10506621-Etoposide,
pubmed-meshheading:10506621-Female,
pubmed-meshheading:10506621-Follow-Up Studies,
pubmed-meshheading:10506621-Humans,
pubmed-meshheading:10506621-Infant,
pubmed-meshheading:10506621-Male,
pubmed-meshheading:10506621-Neuroblastoma,
pubmed-meshheading:10506621-Prognosis,
pubmed-meshheading:10506621-Proto-Oncogene Proteins c-myc,
pubmed-meshheading:10506621-Survivors,
pubmed-meshheading:10506621-Vincristine
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Long-term survivors of advanced neuroblastoma with MYCN amplification: A report of 19 patients surviving disease-free for more than 66 months.
|
|
pubmed:affiliation |
Study Group of Japan for Treatment of Advanced Neuroblastoma, Izumi, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
